Correlation Between Crispr Therapeutics and Arcellx
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Arcellx, you can compare the effects of market volatilities on Crispr Therapeutics and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Arcellx.
Diversification Opportunities for Crispr Therapeutics and Arcellx
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Crispr and Arcellx is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Arcellx go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Arcellx
Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 3.23 times less return on investment than Arcellx. In addition to that, Crispr Therapeutics is 1.1 times more volatile than Arcellx. It trades about 0.02 of its total potential returns per unit of risk. Arcellx is currently generating about 0.07 per unit of volatility. If you would invest 2,782 in Arcellx on November 28, 2024 and sell it today you would earn a total of 3,348 from holding Arcellx or generate 120.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Arcellx
Performance |
| Timeline |
| Crispr Therapeutics |
| Arcellx |
Crispr Therapeutics and Arcellx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Arcellx
The main advantage of trading using opposite Crispr Therapeutics and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |